Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02982174 · ClinicalTrials.gov registry record
Evaluation of the Signal to Noise Ratio at Various Retinal Layers
A clinical trial, sponsored by Topcon Medical Systems.
- Completed
- Registry status
- 15
- Enrollment target
NCT02982174: Completed study, sponsored by Topcon Medical Systems.
NCT02982174 is a clinical trial that has completed, run by Topcon Medical Systems. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02982174 has completed, sponsored by Topcon Medical Systems.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
Compare the signal to noise ratio of each device at various retinal layers.
Interventions
- DEVICE 3D OCT-1 Maestro
- DEVICE DRI OCT Triton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2016-12 |
| Est. Completion | 2017-01 |
What the finished NCT02982174 record still lists
NCT02982174 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which 3D OCT-1 Maestro is the first listed.
NCT02982174 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02982174 about?
NCT02982174 is a clinical study titled "Evaluation of the Signal to Noise Ratio at Various Retinal Layers". Compare the signal to noise ratio of each device at various retinal layers.
What is the current status of trial NCT02982174?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2016-12. Estimated completion is 2017-01.
What interventions are being tested in trial NCT02982174?
The interventions under investigation include: 3D OCT-1 Maestro (DEVICE), DRI OCT Triton (DEVICE).
Who is sponsoring clinical trial NCT02982174?
This trial is sponsored by Topcon Medical Systems, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia